Safety of sildenafil in the treatment of erectile dysfunction in patients with obstructive sleep apnoea

Expert Opinion on Drug Safety

Volumn 6, Issue 4, 2007, Pages 423-430

  Perimenis, Petros ^a   Giannitsas, Konstantinos ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Erectile dysfunction; Obstructive sleep apnoea; Safety; Sildenafil

Indexed keywords

GUANOSINE PHOSPHATE; NITRIC OXIDE; PHOSPHODIESTERASE V; PLACEBO; SILDENAFIL; TADALAFIL; VARDENAFIL; PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; SULFONE;

BEDTIME DOSAGE; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG SAFETY; ENZYME INHIBITION; ENZYME LOCALIZATION; ERECTILE DYSFUNCTION; FLUSHING; HUMAN; MUSCLE CONTRACTION; NONHUMAN; NOSE CONGESTION; NOSE OBSTRUCTION; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; SINGLE DRUG DOSE; SLEEP APNEA SYNDROME; VASODILATATION; ANIMAL; IMPOTENCE; MALE;

ANIMALS; HUMANS; IMPOTENCE; MALE; PIPERAZINES; PURINES; SLEEP APNEA, OBSTRUCTIVE; SULFONES;

EID: 34548495334     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740338.6.4.423     Document Type: Review

References (57)

1. NO AUTHORS LISTED: Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of the American Academy of Sleep Medicine Task Force. Sleep (1999) 22(5):667-689.
2. YOUNG T, PALTA M, DEMPSEY J, SKATRUD J, BADR S: The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med. (1993) 328(17):1230-1235.
3. LAVIE P: Incidence of sleep apnoea in a presumably healthy working population: significant relationship with excessive day time sleepiness. Sleep (1983) 6(4):312-318.
4. LACASSE Y, GODBOUT C, SERIES F: Health-related quality of life in obstructive sleep apnoea. Eur. Respir. J. (2002) 19(3):499-503.
5. PANKOW W, NABEB, LIES A et al.: Influence of sleep apnoea on 24-hour blood pressure. Chest (1997) 112(5):1253-1258.
6. NIETO FJ, YOUNG TB, LIND BK et al.: Association of sleep disordered breathing, sleep apnoea and hypertension in a large community-based study. Sleep Heart Health Study. JAMA (2000) 283 (14): 1829-1836.
7. SHAHAR E, WHITNEY CW, REDLINE S et al.: Sleep-disordered breathing and cardiovascular disease: cross-sectional results the Sleep Heart Health Study. Am. J. Respir. Crit. Care Med. (2001) 163(1):19-25.
8. DYKEN ME, SOMERS VK, YAMADA T, REN ZY, ZIMMERMAN MB: Investigating the relationship between stroke and obstructive sleep apnoea. Stroke (1996) 27(3):401-407.
9. TISHLER PV, LARKIN EK, SCHLUCHTER MD, REDLINE S: Incidence of sleep-disordered breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disordered breathing. JAMA (2003) 289(17):2230-2237.
10. STRADLING JR, CROSBY JH: Predictors and prevalence of obstructive sleep apnoea and snoring in 1001 middle aged men. Thorax (1991) 46(2):85-90.
11. BIXLER EO, VGONTZAS AN, TEN HAVE T, TYSON K, KALES A: Effects of age on sleep apnoea in men: I. Prevalence and severity. Am. J. Respir. Crit. Care Med. (1998) 157(1):144-148.
12. NO AUTHORS LISTED: NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA (1993) 270(1):83-90.
13. ROSEN RC, FISHER WA, EARDLEY I, NIEDERBERGER C, NADEL A, SAND M: The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr. Med. Res. Opin. (2004) 20(5):607-617.
14. FELDMAN HA, GOLDSTEIN I, HATZICHRISTOU DG, KRANE RJ, MCKINLAY JB: Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J. Urol. (1994) 151(1):54-61.
15. ALTHOF SE: Quality of life and erectile dysfunction. Urology (2002) 59(6):803-810.
16. CARSON CC, LUE TF: Phosphodiesterase 5 inhibitors for erectile dysfunction. BJU Int. (2005) 96(3):257-280.
17. PRESSMAN MR, DIPHILLIPO MA, KENDRICK JI, CONROY K, FRY JM: Problems in the interpretation of nocturnal penile tumescence studies: disruption of sleep by occult sleep disorders. J. Urol. (1986) 136(3):595-598.
18. HIRSHKOWITZ M, KARACAN I, ARCASOY MO, ACIK G, NARTER EM, WILLIAMS RL: Prevalence of sleep apnoea in men with erectile dysfunction. Urology (1990) 36(3):232-234.
19. SCHIAVI RC, MANDELI J, SCHREINER ENGEL P, CHAMBERS A: Aging, sleep disorders, and male sexual function. Biol. Psychiatry (1991) 30(1):15-24.
20. SEFTAL AD, STROHL KP, LOYE TL, BAYARD D, KRESS J, NETZER NC: Erectile dysfunction and symptoms of sleep disorders. Sleep (2000) 25(6):643-647.
21. HERUTI R, SHOCHAT T, TEKES-MANOVA D, ASHKENAZI I, JUSTO D: Association between erectile dysfunction and sleep disorders measured by self-assessment questionnaires in adult men. J. Sex. Med. (2005) 2(4):543-550.
22. MARGEL D, COHEN M, LIVNE PM, PILLAR G: Severe, but not mild, obstructive sleep apnoea syndrome is associated with erectile dysfunction. Urology (2004) 63(3):545-549.
23. TELOKEN PE, SMITH E, LODOWSKY C, FREEDOM T, MULHALL JP: Defining association between sleep apnoea syndrome and erectile dysfunction. Urology (2006) 67(5):1033-1037.
24. GONCALVES MA, GUILLEMINAULT C, RAMOS E, PALHA A, PAIVA T: Erectile dysfunction, obstructive sleep apnoea syndrome and nasal CPAP treatment. Sleep Med. (2005) 6(4):333-339.
25. KARACAN I, KARATAS M: Erectile dysfunction in sleep apnoea and response to CPAP. J. Sex. Marital Ther. (1995) 21(4):239-247.
26. PERIMENIS P, KARKOULIAS K, KONSTANTINOPOULOS A et al.: The impact of long-term conventional treatment for overlap syndrome (obstructive sleep apnoea and chronic obstructive pulmonary disease) on concurrent erectile dysfunction. Respir. Med. (2007) 101(2):210-216.
27. FANFULLA F, MALAGUTI S, MONTAGA T et al.: Erectile dysfunction in men with obstructive sleep apnoea: an early sign of nerve involvement. Sleep (2000) 23(6):775-781.
28. MC COWEN KC, MALHOTRA A: The correlation between obstructive sleep apnoea and low gonadotropin secretion in men. Sleep Med. (2003) 4(1):83-84.
29. RAJFER J, ARONSON WJ, BUSH PA, DOREY FJ, IGNARRO J: Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N. Engl. J. Med. (1992) 326(2):90-94.
30. IP MS, LAM B, CHAN LY al.: Circulating nitric oxide is suppressed in obstructive sleep apnoea and is reversed by nasal continuous positive airway pressure. Am. J. Respir. Crit. Care (2000) 162(6):2166-2171.
31. KATO M, ROBERTS-THOMSON P, PHILLIPS BG et al.: Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnoea. Circulation (2000) 102(21):2607-2610.
32. WHITE DP: Pathogenesis of obstructive and central sleep apnoea. Am. J. Respir. Crit. Care Med. (2005) 172(11):1363-1370.
33. FOGEL RB, TRINDER J, MALHOTRA A et al.: Within-breath control of genioglossal muscle activation in humans: effect of sleep-wake state. J. Physiol. (2003) 550(3):899-910.
34. BALLARD SA, GINGELL CJ, TANG K, TURNER LA, PRICE ME, NAYLOR AM: Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities cyclic nucleotide phosphodiesterase isozymes. J. Urol. (1998) 159(6):2164-2171.
35. BOOLELL M, ALLEN MJ, BALLARD SA et al.: Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int. J. Impot. Res. (1996) 8(2):47-52.
36. LIN CS, LIN G, XIN ZC, LUE TF: Expression, distribution and regulation of phosphodiesterase 5. Curr. Pharm. Des. (2006) 12(27):3439-3457.
37. MOTAMED M, SANDHU D, MURTY GE: Sildenafil and nasal obstruction. J. Otolaryngol. (2003) 32(4):259-261.
38. KIROGLU AF, BAYRAKLI H, YUCA K, CANKAYA H, KIRIS M: Nasal obstruction as a common side-effect of sildenafil citrate. Tohoku. J. Exp. Med. (2006) 208(3):251-254.
39. STAMLER JS, MEISSNER G: Physiology of nitric oxide in skeletal musde. Physiol. Rev. (2001) 81(1):209-237.
40. KOBZIK L, REID MB, BREDT DS, STAMLER JS: Nitric oxide in skeletal muscle. Nature (1994) 372(6506):546-548.
41. MURAD F: The 1996 Albert Lasker Medical Research Awards. Signal transduction using nitric oxide and cyclic guanosine monophosphate. JAMA (1996) 276(14):1189-1192.
42. KING-VANVLACK CE, CURTIS SE, MEWBURN JD, CAIN SM, CHAPLER CK: Role of endothelial factors in active hyperemic responses in contracting canine muscle. J. Appl. Physiol. (1995) 79(1):107-112.
43. MURRANT CS, WOODLEY NE, BARCLAY JK: Effect of nitroprusside and endothelium-derived products on slow-twitch skeletal muscle function in vitro. Can. J. Physiol. Pharmacol. (1994) 72(9):1089-1093.
44. WHARTON J, STRANGE JW, MOLLER GM et al.: Anti-proliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells. Am. J. Respir. Crit. Care Med. (2005) 172(1):105-113.
45. ZHU B, STRADA S, STEVENS T: Cyclic GMP-specific phosphodiesterase 5 regulates growth and apoptosis in pulmonary endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. (2005) 289(2):196-206.
46. GALIE N, GHOFRANI HA, TORBICKI A et al.: Sildenafil citrate therapy for pulmonary arterial hypertension. N. Engl. J. Med. (2005) 353(20):2148-2157.
47. ZHAO L, MASON NA, MORRELL NW et al.: Sildenafil inhibits hypoxia-induced pulmonary hypertension. Circulation (2001) 104(4):424-428.
48. RICHALET JP, GRATADOUR P, ROBACH P et al.: Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension. Am. J. Respir. Crit. Care Med. (2005) 171(3): 275-281.
49. GHOFRANI HA, REICHENBERGER F, KOHSTALL MG et al.: Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial. Ann. Intern. Med. (2004) 141(3):169-177.
50. KLEINSASSER A, LOECKINGER A, HOERMANN C et al.: Sildenafil modulates hemodynamics and pulmonary gas exchange. Am. J. Respir. Crit. Care Med. (2001) 163(2):339-343.
51. RICART A, MARISTANY J, FORT N, LEAL C, PAGES T, VISCOR G: Effects of sildenafil on the human response to acute hypoxia and exercise. High Alt. Med. Biol. (2005) 6(1):43-49.
52. ROIZENBLATT S, GUILLEMINAULT C, POYARES D, CINTRA F, KAUATI A, TUFIK S: A double-blind, placebo-controlled, crossover study of sildenafil in obstructive sleep apnoea. Arch. Intern. Med. (2006) 166(16):1763-1767.
53. PERIMENIS P, KARKOULIAS K, MARKOU S et al.: Erectile dysfunction in men with obstructive sleep apnoea syndrome: a randomized study of the efficacy of sildenafil and continuous
54. positive airway pressure. Int. J. Impot. Res. (2004) 16(3):256-260.
55. PERIMENIS P, KARKOULIAS K, KONSTANTINOPOULOS A et al.: Sildenafil versus continuous positive airway pressure for erectile dysfunction in men with obstructive sleep apnea: a comparative study of their efficacy and safety and the patient's satisfaction with treatment. Asian J. Androl. (In Press).
56. PERIMENIS P, KONSTANTINOPOULOS A, KARKOULIAS K, MARKOU S, PERIMENI P, SPYROPOULOS K: Sildenafil combined with continuous positive airway pressure for treatment of erectile dysfunction in men with obstructive sleep apnea. Int. Urol. Nephrol. (In Press).
57. MORALES A, GINGELL C, COLLINS M, WICKER PA, OSTERLOH IH: Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction. Int. J. Impot. Res. (1998) 10(2):69-74.